Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Net Margin (2020 - 2025)

Treace Medical Concepts' Net Margin history spans 6 years, with the latest figure at 10.79% for Q4 2025.

  • For Q4 2025, Net Margin fell 989.0% year-over-year to 10.79%; the TTM value through Dec 2025 reached 26.66%, up 12.0%, while the annual FY2025 figure was 26.66%, 12.0% up from the prior year.
  • Net Margin reached 10.79% in Q4 2025 per TMCI's latest filing, up from 32.62% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 0.9% in Q4 2024 to a low of 57.51% in Q2 2022.
  • Average Net Margin over 5 years is 28.39%, with a median of 30.82% recorded in 2022.
  • Peak YoY movement for Net Margin: plummeted -3271bps in 2022, then surged 2803bps in 2023.
  • A 5-year view of Net Margin shows it stood at 19.79% in 2021, then soared by 55bps to 8.86% in 2022, then decreased by -16bps to 10.25% in 2023, then soared by 91bps to 0.9% in 2024, then plummeted by -1098bps to 10.79% in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Net Margin are 10.79% (Q4 2025), 32.62% (Q3 2025), and 36.97% (Q2 2025).